Home » Topics » Regulatory » Patents

Patents
RSS

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Antibacterial quinolone carboxylic acids prepared at Bayer

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Antiarrhythmic Na+/H+ exchange inhibitors prepared by Hoechst

March 31, 1998

Focus on agents for estrogen deprivation continues at Lilly

March 30, 1998

SKB develops new agents for osteoporosis and related disorders

March 30, 1998

New ocular agents described by Novartis

March 30, 1998

Adenosine derivatives for cardiovascular, lipid disorders

March 30, 1998

Cytokine inhibitors claimed by Novo Nordisk for diabetes and other disorders

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...